Phil Galewitz
Kaiser Health News Senior CorrespondentPhil Galewitz, Senior Correspondent, covers Medicaid, Medicare, long-term care, hospitals, and various state health issues. He has covered the health beat for more than two decades. He is a former board member of the Association of Health Care Journalists. In 2004-05, he was a Kaiser Media Fellow and wrote about community solutions for the uninsured. Before coming to KHN, he was at The Palm Beach Post and was a national health industry writer for The Associated Press and The Patriot-News in Harrisburg, Pennsylvania. He has a bachelor’s in health planning and administration and a master’s in public administration with an emphasis in health policy from Penn State University.
-
Eager to control costs and sickness, hospitals and insurers are trying to help patients access better food, housing and transportation. But so far there is little research showing these efforts work. -
The plan, long endorsed by conservatives, would give the state broad flexibility in running its health insurance program for the poor, while capping annual federal funding for the program. -
The rule would require health officials to review about 2,400 regulations on everything from Medicare benefits to prescription drugs approvals. Those not analyzed within two years would become void. -
A dad in Denver tried to do everything right when COVID-19 symptoms surfaced. But he got a surprising bill from his insurer, which had waived cost sharing for treatment of the coronavirus infection. -
The federal government has waived a law that required an in-person doctor's visit before patients could be prescribed drugs that quell withdrawal symptoms. That's a boon for patients, counselors say. -
A study this month showed giving extra social services to the neediest patients didn't reduce hospital readmissions. Now health advocates say that might not be the right measurement of success. -
The case centers on $12 billion in payments the federal government pledged to insurers to defray their losses in the first years of the health law. Did rescinding those payments send premiums soaring? -
Critics worry that the administration's delays come at a steep cost: Medicare continues to pay for millions of unnecessary exams and patients are being subjected to radiation for no medical benefit. -
The Trump administration says it's trying to clear a path for Americans to import some prescription drugs from Canada. NPR's David Greene speaks with Phil Galewitz of Kaiser Health News.
-
A pricing tool embedded in many prescribing and medical records systems lets doctors see how much each patient is likely to pay out of pocket for medicine. But the tools could be better, doctors say.
